Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Ali Gokyer"'
Publikováno v:
Journal of Pharmaceutical Research, Vol 20, Iss 4, Pp 71-79 (2021)
The use of plant materials as the source of oil and functional foods is becoming more important with the new trends and scientific research. In this study, fig (Ficus carica) seed, which is a rarely found, seed and its oil, have been studied to deter
Externí odkaz:
https://doaj.org/article/e782deb879884cd790a864a1df8864d7
Autor:
Birol Ocak, Ahmet Bilgehan Sahin, Ismail Ertürk, Mustafa Korkmaz, Dilek Erdem, Umut Cakıroglu, Mustafa Karaca, Ahmet Dirican, Omer Fatih Olmez, Sabin Goktas Aydın, Ali Gökyer, Ahmet Kücükarda, Ahmet Gülmez, Perran Fulden Yumuk, Nazim Can Demircan, Abdilkerim Oyman, Teoman Sakalar, Fatih Karatas, Hacer Demir, Ayse Irem Yasin, Adem Deligonul, Bahar Dakiki, Mehmet Refik Goktug, Okan Avcı, Seher Yildiz Tacar, Nazım Serdar Turhal, Gülhan Ipek Deniz, Turgut Kacan, Erdem Cubukcu, Türkkan Evrensel
Publikováno v:
Current Oncology, Vol 31, Iss 9, Pp 5195-5205 (2024)
Background: This study aimed to investigate the effect of cytoreductive nephrectomy (CN) on the survival outcomes of nivolumab used as a subsequent therapy after the failure of at least one anti-vascular endothelial growth factor (VEGF) agent in pati
Externí odkaz:
https://doaj.org/article/e3b91b5047204acf948136cd657f8dec
Autor:
Bulent Erdogan, Erkan Ozcan, Ivo Gokmen, Ali Gokyer, Ahmet Kucukarda, Osman Kostek, MuhammetBekir Hacioglu, Sernaz Uzunoglu, Irfan Cicin
Aim: In this study, we aimed to analyze the effect of prognostic nutritional index and neutrophile lymphocyte ratio on the overall survival (OS) in patients treated with regorafenib. Materials and Methods: Metastatic colorectal cancer (CRC) patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a2233373efef4e578a6dd4efddf2505
https://hdl.handle.net/11424/290935
https://hdl.handle.net/11424/290935
Autor:
Bulent, Erdogan, Osman, Kostek, Muhammet, Bekir Hacioglu, Ali, Gokyer, Ahmet, Kucukarda, Erkan, Ozcan, Ivo, Gokmen, Sernaz, Uzunoglu, Irfan, Cicin
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 26(5)
To demonstrate whether early changes in systemic inflammatory markers are related with pazopanib treatment response in soft tissue sarcoma and renal cell carcinoma.Forty-one patients with metastatic clear cell renal carcinoma (mRCC) (n=22) and advanc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e6cc853a93de425a118b1561cf4568dd
https://pubmed.ncbi.nlm.nih.gov/34761635
https://pubmed.ncbi.nlm.nih.gov/34761635
Autor:
Mehmet, Engin Ozekin, Ali, Gokyer, Ahmet, Kucukarda, Osman, Kostek, Kubilay, Issever, Bulent, Erdogan
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 26(5)
In this study, we aimed to determine the factors which affect post-progression survival (PPS) and overall survival (OS) in patients with metastatic colorectal cancer.87 patients with metastatic colorectal cancer had been followed up with palliative c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::41970053bac459776800855aa0f3a446
https://pubmed.ncbi.nlm.nih.gov/34761596
https://pubmed.ncbi.nlm.nih.gov/34761596
Autor:
Alper, Topal, Sezin, Sayın, Ali, Gokyer, Ahmet, Kucukarda, Osman, Kostek, Muhammet, Bekir Hacıoglu, Sernaz, Uzunoglu, Bulent, Erdogan, Irfan, Cicin
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 26(4)
In this study, we aimed to compare the data of sunitinib and pazopanib used in the first-line treatment of metastatic renal cell carcinoma (RCC) cases and to evaluate the effective factors in terms of survival.The records of 125 patients with metasta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b2489c24ff23a87babff741eb58cbe2c
https://pubmed.ncbi.nlm.nih.gov/34565028
https://pubmed.ncbi.nlm.nih.gov/34565028
Autor:
Ali, Gokyer, Ahmet, Kucukarda, Osman, Kostek, Sezin, Sayin, Nuray, Can, Bekir, Hacıoglu, Bulent, Erdogan, Sernaz, Uzunoglu, Irfan, Cicin
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 26(3)
This study aimed to reveal the relationship between the level of galectin-3 expression and the depth of response to neoadjuvant therapy in bladder tumor tissue with muscle invasion revealed by transurethral biopsy.The percentage of galectin-3 stainin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4ac634d5fc8fa25bac0c062a294d7004
https://pubmed.ncbi.nlm.nih.gov/34268970
https://pubmed.ncbi.nlm.nih.gov/34268970
Autor:
Ahmet, Kucukarda, Ali, Gokyer, Ivo, Gokmen, Muhammed, Bekir Hacioglu, Osman, Kostek, Nazmi, Kurt, Derya, Karabulut, Nermin, Tuncbilek, Sernaz, Uzunoglu, Bulent, Erdogan, Irfan, Cicin
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 26(3)
We aimed to assess whether skeletal muscle loss during EGFR thyrosine kinase inhibitor therapy of advance non-small cell lung cancer patients is an independent prognostic factor for progression-free survival (PFS) and overal survival (OS).A total of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2fd827c318d0a0e85ae829ebce2f5d17
https://pubmed.ncbi.nlm.nih.gov/34268945
https://pubmed.ncbi.nlm.nih.gov/34268945
Autor:
Birol, Yildiz, Ahmet, Kucukarda, Ali, Gokyer, Atike, Gokcen Demiray, Semra, Paydas, Ipek, Pinar Aral, Ozge, Gumusay, Ahmet, Bilici, Nadiye, Akdeniz, Aykut, Bahceci, Hacer, Demir, Ece, Esin, Ummugul, Üyeturk, Ilker, Nihat Okten, Ismail, Erturk, Haci Mehmet, Turk, Ulas Serkan, Topaloglu, Tugba, Basoglu, Nazim, Serdar Turhal, Havva, Yesil Cinkir, Serkan, Menekse, Yagmur, Cakmak, Yuksel, Urun, Ramazan, Acar, Engin, Kut, Pinar, Dal, Teoman, Sakalar, Oktay, Halit Aktepe, Nuri, Karadurmus
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 25(2)
The purpose of this study was to determine whether primary tumor localization may be a risk factor for relapse and survival in seminomatous germ cell tumors (GCT) patients.In our study, 612 seminomatous GCT patients diagnosed in 22 centers between 01
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ffa3e8dbc74131326a26cd160fbfd703
https://pubmed.ncbi.nlm.nih.gov/32521916
https://pubmed.ncbi.nlm.nih.gov/32521916
Autor:
Muhammet, Bekir Hacioglu, Osman, Kostek, Nazmi, Kurt, Ahmet, Kucukarda, Ali, Gokyer, Fethi Emre, Ustabasioglu, Fatih, Karatas, Nermin, Tuncbilek, Sernaz, Uzunoglu, Ahmet, Bilici, Irfan, Cicin, Bulent, Erdogan
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 24(5)
To assess whether regorafenib and TAS-102 treatments are associated with a change in Skeletal Muscle Area (SMA) as well as to compare Skeletal Muscle Mass (SMM) loss levels between regorafenib and TAS-102 treatments and prognostic significance in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1e9f6b9919fdad63fc8f87717740d380
https://pubmed.ncbi.nlm.nih.gov/31786894
https://pubmed.ncbi.nlm.nih.gov/31786894